Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Fisher

Stroke

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Stroke|December 18, 2010
New approaches to neuroprotective drug developmentMarc Fisher
Stroke|May 17, 2003
Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3Marc Fisher,
Stroke|September 1, 2007
Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental strokeNils Henninger, Marc Fisher
Stroke|July 10, 2002
Considering the role of heparin and low-molecular-weight heparins in acute ischemic strokeMajaz Moonis, Marc Fisher
Stroke|December 12, 2022
Improving Large Animal Ischemic Stroke Models for Translational Studies in the Era of RecanalizationShen Li, Marc Fisher
Stroke|October 16, 2010
Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?Jane G Morris, Swaraj Singh, Marc Fisher
Stroke|May 30, 2009
Cardiac workup of ischemic stroke: can we improve our diagnostic yield?Jane G Morris, E Jesus Duffis, Marc Fisher
Stroke|July 24, 2010
Current practice versus willingness to enroll in clinical trials: paradox among vascular neurologists about treatment for acute ischemic strokeRamy El Khoury, Marc Fisher, Sean I Savitz
Stroke|July 22, 2021
Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XIPatrick Lyden, Alastair Buchan, Johannes Boltze, et al.
Stroke|December 17, 2008
Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trialsMaria Philip, Michael Benatar, Marc Fisher, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Stroke|December 18, 2010
New approaches to neuroprotective drug developmentMarc Fisher
Stroke|May 17, 2003
Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3Marc Fisher,
Stroke|September 1, 2007
Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental strokeNils Henninger, Marc Fisher
Stroke|July 10, 2002
Considering the role of heparin and low-molecular-weight heparins in acute ischemic strokeMajaz Moonis, Marc Fisher
Stroke|December 12, 2022
Improving Large Animal Ischemic Stroke Models for Translational Studies in the Era of RecanalizationShen Li, Marc Fisher
Stroke|October 16, 2010
Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good?Jane G Morris, Swaraj Singh, Marc Fisher
Stroke|May 30, 2009
Cardiac workup of ischemic stroke: can we improve our diagnostic yield?Jane G Morris, E Jesus Duffis, Marc Fisher
Stroke|July 24, 2010
Current practice versus willingness to enroll in clinical trials: paradox among vascular neurologists about treatment for acute ischemic strokeRamy El Khoury, Marc Fisher, Sean I Savitz
Stroke|July 22, 2021
Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XIPatrick Lyden, Alastair Buchan, Johannes Boltze, et al.
Stroke|December 17, 2008
Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trialsMaria Philip, Michael Benatar, Marc Fisher, et al.
Pageof 6